| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT07146230 The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung… |
date change Primary completion pushed: 2027-12 -> 2028-04 |
| 2026-06-10 | NCT07146230 The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung… |
date change Completion pushed: 2028-10 -> 2029-02 |
| 2026-05-16 | NCT06606847 A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation… |
date change Primary completion moved earlier: 2026-06-30 -> 2026-05-04 |
| 2026-05-16 | NCT06606847 A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation… |
date change Completion moved earlier: 2027-06-30 -> 2027-03-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05221840 | A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05061550 | Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer | Non-small Cell Lung Cancer | Recruiting |
| NCT04668300 | Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma | Metastatic Angiosarcoma | Active, Not Recruiting |
| NCT04940286 | Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment… | Borderline Resectable Pancreatic Adenocarcinoma | Active, Not Recruiting |
| NCT06606847 | A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT07146230 | The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung… | Non-small Cell Lung Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT03381274 | Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT03742102 | A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast… | Triple Negative Breast Neoplasms | Active, Not Recruiting |
| NCT04068610 | COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as… | Metastatic Microsatellite-stable Colorectal Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT03819465 | A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC | Metastatic Non-Small Cell Lung Cancer (NSCLC) | Active, Not Recruiting |